Acumen Pharmaceuticals, Inc.

NASDAQ:ABOS

1.56 (USD) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 0000.29000000000001.4360.730.1510.226
Cost of Revenue 00.0450.0440.0390.040.0530.0520.0490.0440.0390.0370.0030.0012.2542.5311.0262.9941.9272.05
Gross Profit 0-0.045-0.0440.251-0.04-0.053-0.052-0.049-0.044-0.039-0.037-0.003-0.001-2.254-2.5310.41-2.264-1.776-1.824
Gross Profit Ratio 0000.866000000000000.286-3.101-11.762-8.071
Reseach & Development Expenses 27.24719.53312.44913.29311.1799.1338.71310.7468.3097.3215.9855.6731.82.2542.5781.0262.9941.9272.05
General & Administrative Expenses 5.0184.8485.3255.1934.864.3454.4223.5023.0623.093.2212.7422.1351.1871.2150.6440.2260.2590.222
Selling & Marketing Expenses 000-0.039000000000000000
SG&A 5.0184.8485.3255.1544.864.3454.4223.5023.0623.093.2212.7422.1351.1871.2150.6440.2260.2590.222
Other Expenses 00-0.054-0.021-0.042-0.016-0.004-0.01-0.00200.0010.0040.0190.0190.0091.107000
Operating Expenses 32.26524.38117.77418.44716.03913.47813.13514.24811.37110.4119.2068.4153.9353.4413.7932.7772.492.1862.272
Operating Income -32.265-24.381-17.774-18.486-16.039-13.478-13.135-14.248-11.371-10.411-9.206-8.415-3.935-3.441-3.793-1.341-2.49-2.035-2.046
Operating Income Ratio 000-63.74500000000000-0.934-3.411-13.477-9.053
Total Other Income Expenses Net 2.53.8442.9011.9893.0821.8681.8281.3820.6610.260.0770.0660.033-57.917-23.2040.586000.001
Income Before Tax -29.765-20.537-14.873-16.497-12.957-11.61-11.307-12.866-10.71-10.151-9.129-8.349-3.902-61.358-26.997-0.755-2.49-2.035-2.045
Income Before Tax Ratio 000-56.88600000000000-0.526-3.411-13.477-9.049
Income Tax Expense 00-0.0443.752-0.04-1.884-1.8280.998-0.661-0.26-0.077-0.066-0.05657.91723.204-0.586-2.49-2.035-0.001
Net Income -29.765-20.537-14.873-16.497-12.957-11.61-9.479-13.864-10.049-9.891-9.052-8.349-3.902-61.358-26.997-0.755-2.49-2.035-2.045
Net Income Ratio 000-56.88600000000000-0.526-3.411-13.477-9.049
EPS -0.5-0.34-0.25-0.28-0.24-0.28-0.23-0.34-0.25-0.24-0.22-0.22-0.1-1.59-0.73-0.026-0.087-0.071-0.071
EPS Diluted -0.5-0.34-0.25-0.28-0.24-0.28-0.23-0.34-0.25-0.24-0.22-0.22-0.1-1.59-0.73-0.026-0.087-0.071-0.071
EBITDA -28.693-19.488-13.829-13.471-16.039-11.557-11.255-14.236-11.371-10.411-9.169-8.369-3.935-3.441-3.793-1.342-2.49-2.0350.001
EBITDA Ratio 000-63.6100000000000-0.935-3.411-13.477-9.053